News
DMD Advocates represents HBM Healthcare Investment and others in INR 850 crore pre-IPO round in OneSource Specialty Pharma
10 Jan 2025
- DMD Advocates
- Deal Reporting
DMD Advocates advised HBM Healthcare Investments and other associated investors in leading Onesource’s fundraising of approximately INR 850 crores through a pre-listing round. OneSource Specialty Pharma Limited (formerly known as Stelis Biopharma Limited), a contract development and manufacturing organization (CDMO) platform, is an associate of Strides Pharma and its shares are to be listed shortly.
The capital raised will support Onesource’s growth, advance its research and development, and enhance its product offerings, which will strengthen the company’s market position ahead of its IPO.
The transaction was led by Ayesha Rai (Partner) along with Pooja Shah (Principal Associate) and Vanshikha Choraria (Associate). Vihang Virkar (Lead Partner) acted as the engagement partner on this assignment.
